Patent · US Active

Circulating Angiopoietin-2 (Ang-2) for the prediction of recurrence of atrial fibrillation

US11644472B2 · kind B2 · utility

0Cited by

4References

9Claims

0Family size

Assignee

Roche Diagnostics Operations, Inc. · US

Inventors

Herbert Andres · Penzberg, DE
Dirk Block · Bichl, DE
Johann Karl · Peißenberg, DE
Peter Kastner · Murnau am Staffelsee, DE
Ursula-Henrike Wienhues-Thelen · Krailling, DE
Roberto Latini · Milano, IT
Serge Masson · Monza, IT
Andre Ziegler · Läufelfingen, CH
Edelgard Kaiser · Chur, CH
Stefan Palme · Bichl, DE
Markus Thomas · Rheinfelden (Baden), DE
Simona Barlera · Tradate, IT

Key dates

Filing date	Dec 12, 2018
Grant date	May 9, 2023
Priority date	—
Expiry date	Dec 12, 2038

Classification

Technology area (CPC G)Physics
CPC primaryG01N2800/54
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

A method for predicting the risk of recurrence of Atrial Fibrillation in a subject based on measuring the amount of the biomarker Angiopoietin-2 (Ang-2) and optionally of at least one further biomarker in a sample from the subject is described. Also described is a method of diagnosing Atrial Fibrillation in a subject suspected to suffer from Atrial Fibrillation based on measuring the amount of the biomarker Angiopoietin-2 (Ang-2) and optionally of at least one further biomarker in a sample from the subject. Also described are devices adapted to carry out the method of the present disclosure.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.